genetic testing
FDA OKs 23andMe Test
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
23andMe Expands to U.K.
23andMe Expands to U.K.
Kerry Grens | Dec 2, 2014
British consumers can buy the genetic testing-associated health prediction service forbidden by the US government.
Snakebites Get DNA Fingerprint Treatment
Snakebites Get DNA Fingerprint Treatment
Bob Grant | Nov 4, 2014
Researchers have developed a technique for determining the species of snake responsible for a bite by sequencing genetic material from the fang marks.
Australian Court Upholds Patents on Human Genes
Australian Court Upholds Patents on Human Genes
Molly Sharlach | Sep 8, 2014
The Federal Court of Australia rejected an appeal of a ruling that allows companies to patent isolated human genes.
Patent Plea Ping Pong
Patent Plea Ping Pong
Kerry Grens | Aug 21, 2014
A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.
DNA Ancestry for All
DNA Ancestry for All
Tracy Vence | Jul 10, 2014
Big ad campaigns and celebrity involvement have helped increase public interest in genetic genealogy, but helping consumers understand their DNA ancestry testing results remains difficult.
Speaking of Science
Speaking of Science
The Scientist Staff | Jan 1, 2014
January 2014's selection of notable quotes
The Right to Know—or Not
The Right to Know—or Not
Tracy Vence | Dec 12, 2013
Consumers, patients, and study participants should be made aware of potential incidental findings, according to a federally-appointed bioethics panel.
23andMe Now Facing Lawsuit
23andMe Now Facing Lawsuit
Kerry Grens | Dec 4, 2013
Shortly after getting in trouble with the Food and Drug Administration, the personal genetic testing company is slapped with a class action lawsuit.
FDA to 23andMe: Stop Marketing Kits
FDA to 23andMe: Stop Marketing Kits
Kerry Grens | Nov 26, 2013
The US Food and Drug Administration blocks the marketing of unapproved genetic tests.